Skip to main content

Table 7 Association of patients’ socio-characteristics with pharmacovigilance awareness, knowledge of adverse drug reaction and reporting of experienced reactions

From: Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria

Variables

Knowledge of ADR definition

PV Awareness

Reporting of experienced ADRs

Adequate

Inadequate

Yes

No

Yes

No

Age (year)

 18–40

118 (82.5)

188 (86.6)

25 (80.6)

281 (85.4)

48 (71.6)

258 (88.1)

 41 and above

25 (17.5)

29 (13.4)

6 (19.4)

48 (14.6)

19 (28.4)

35 (11.9)

 

X2 = 1.147; p = 0.284

X2 = 0.505; p = 0.478

X2 = 11.521; p = 0.001*

Gender

 Male

19 (13.3)

30 (13.8)

4 (12.9)

45 (13.7)

8 (11.9)

41 (14.0)

 Female

124 (86.7)

187(86.2)

27 (87.1)

284 (86.3)

59 (88.1)

252 (86.0)

 

X2 = 0.021; p = 0.884

FET = 0.014; p = 1.000

X2 = 0.195; p = 0.658

Marital status

 Single

55 (38.5)

60 (27.6)

10 (32.3)

105 (31.9)

13 (19.4)

102 (34.8)

 Married

84 (58.7)

152 (70.0)

20 (64.5)

216 (65.7)

52 (77.6)

184 (62.8)

 Widowed/Divorced

4 (2.8)

5 (2.3)

1 (3.2)

8 (2.4)

2 (3.0)

7 (2.4)

 

FET = 4.973; p = 0.083

FET = 0.478; p = 0.801

FET = 6.343; p = 0.037*

Occupation

 Civil/public servant

41 (28.7)

55 (25.3)

13 (41.9)

83 (25.2)

21 (31.3)

75 (25.6)

 Self-employed

71 (49.7)

116 (53.5)

11 (35.5)

176 (53.5)

30 (44.8)

157 (53.6)

 No active employment

31 (21.7)

46 (21.2)

7 (22.6)

70 (21.3)

16 (23.9)

61 (20.8)

 

X2 = 0.607; p = 0.738

X2 = 4.757; p = 0.093

X2 = 1.728; p = 0.421

Educational qualification

 No formal education/Primary

6 (4.2)

26 (12.0)

1 (3.2)

31 (9.4)

4 (6.0)

28 (9.6)

 Secondary

54 (37.8)

94 (43.3)

2 (6.5)

146 (44.4)

25 (37.3)

123 (42.0)

 Post-secondary/Tertiary

83 (58.0)

97 (44.5)

28 (90.3)

152 (46.2)

39 (56.7)

142 (48.5)

 

X2 = 9.594; p = 0.008*

FET = 23.619; p < 0.001*

X2 = 1.820; p = 0.402

  1. FET Fischer’s Exact Test, X2 Pearson Chi-square, *significant difference with Fischer’s Exact or Pearson Chi-square test, PV Pharmacovigilance, ADR Adverse drug reaction. Level of statistical significance p < 0.05